# Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy

Study · id `cardio:ct-nct01066715` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01066715](<https://clinicaltrials.gov/study/NCT01066715>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01066715

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 421 participants.

## Technical summary

Registry record NCT01066715. Randomized; quadruple masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2011-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 421 participants (enrolled count; ClinicalTrials.gov record NCT01066715, source copy `cardio:ctgov-nct01066715-2011-10-04`, retrieved 2026-10-26)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT01066715, source copy `cardio:ctgov-nct01066715-2011-10-04`, retrieved 2026-10-26)
- Primary completion: 2011-07 (actual) (ClinicalTrials.gov record NCT01066715, source copy `cardio:ctgov-nct01066715-2011-10-04`, retrieved 2026-10-26)
- Completion: 2011-07 (actual) (ClinicalTrials.gov record NCT01066715, source copy `cardio:ctgov-nct01066715-2011-10-04`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01066715, source copy `cardio:ctgov-nct01066715-2011-10-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01066715-2011-10-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): XOMA 052
- Intervention (Drug): Placebo
- Lead sponsor: XOMA (US) LLC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: e18eb00f913472d01252aa561b09f4ad645a4adbc2280c47518fe5615fc5e458
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
